Healthcare provider profile · identity verified

Albert Chao, MD

Family Practice · FAYETTEVILLE, NC · NPI 1225020068

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	433	119
Atorvastatin Calcium	Atorvastatin Calcium	418	121
Metformin Hcl	Metformin Hcl	244	69
Omeprazole	Omeprazole	231	56
Hydrochlorothiazide	Hydrochlorothiazide	227	56
Levothyroxine Sodium	Levothyroxine Sodium	222	59
Losartan Potassium	Losartan Potassium	222	53
Lisinopril	Lisinopril	216	65
Simvastatin	Simvastatin	166	43
Tamsulosin Hcl	Tamsulosin Hcl	139	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	38
Rosuvastatin Calcium	Rosuvastatin Calcium	137	37
Furosemide	Furosemide	123	36
Sertraline Hcl	Sertraline Hcl	116	28
Gabapentin	Gabapentin	112	32
Potassium Chloride	Potassium Chloride	101	28
Montelukast Sodium	Montelukast Sodium	97	29
Pantoprazole Sodium	Pantoprazole Sodium	97	38
Zolpidem Tartrate	Zolpidem Tartrate	97	13
Metoprolol Tartrate	Metoprolol Tartrate	94	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	23
Carvedilol	Carvedilol	87	18
Metoprolol Succinate	Metoprolol Succinate	83	25
Alprazolam	Alprazolam	82	22
Glimepiride	Glimepiride	79	20
Albuterol Sulfate Hfa	Albuterol Sulfate	71	33
Trazodone Hcl	Trazodone Hcl	69	17
Clopidogrel	Clopidogrel Bisulfate	68	17
Ozempic	Semaglutide	68	11
Eliquis	Apixaban	62	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	15
Pravastatin Sodium	Pravastatin Sodium	55	17
Citalopram Hbr	Citalopram Hydrobromide	54	12
Esomeprazole Magnesium	Esomeprazole Magnesium	54	11
Meloxicam	Meloxicam	54	13
Rybelsus	Semaglutide	53	12
Atenolol	Atenolol	49	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	17
Fluticasone Propionate	Fluticasone Propionate	47	16
Ibuprofen	Ibuprofen	46	16
Tresiba Flextouch U-100	Insulin Degludec	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Allopurinol	Allopurinol	40	suppressed
Ezetimibe	Ezetimibe	39	13
Synthroid	Levothyroxine Sodium	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	37	suppressed
Jardiance	Empagliflozin	35	14
Finasteride	Finasteride	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Famotidine	Famotidine	31	suppressed
Glipizide	Glipizide	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Baclofen	Baclofen	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Sodium Chloride	0.9 % Sodium Chloride	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Diazepam	Diazepam	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Azithromycin	Azithromycin	20	19
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Fluconazole	Fluconazole	20	12
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Bupropion Xl	Bupropion Hcl	19	suppressed
Colchicine	Colchicine	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Clonidine	Clonidine	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Risperidone	Risperidone	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error